The first stop for professional medicines advice

Guidance

670 results

Applied filters

Managing interactions with direct oral anticoagulants (DOACs)

5 January 2024Interactions with apixaban, dabigatran, edoxaban or rivaroxaban can result in increased risks of a bleed or thrombosis. We advise on management options.

Understanding direct oral anticoagulant (DOAC) interactions

5 January 2024It is important to understand the risks, mechanisms of interactions and actions to take when prescribing medicines with DOACs.

Use of nefopam for chronic pain

5 January 2024Nefopam is licensed for chronic pain relief. However, evidence to support use is limited and is not included in national guidelines.

Considerations for developing national PGD templates

3 January 2024Decisions to develop PGD templates under the national Medicines Governance Do Once Programme depend on a variety of factors and advice on exclusions is given.

Managing interactions with methotrexate

28 December 2023Guidance on frequently asked questions on medicine interactions with low dose methotrexate.

Using metronidazole during breastfeeding

22 December 2023Metronidazole can be used during breastfeeding for most usual treatment courses. Recommendations apply to full term, healthy infants.

Complex medication regimens: supporting adherence

20 December 2023Interventions and tools to help improve medication adherence, where complex regimens (capability) have been identified as a factor

Manual dexterity: supporting adherence

20 December 2023Interventions and tools to help improve medication adherence, where manual dexterity (capability) has been identified as a factor

Defining and understanding medication adherence

20 December 2023Definitions, evidence and the importance of effective consultations, with tools and interventions to facilitate medication adherence.

Explaining how to use or take medicines: supporting adherence

20 December 2023Interventions and tools to help improve medication adherence, where comprehension (capability) or language (opportunity) issues have been identified as factors.